Skip to main content
SpringerLink
Log in

Valvular Diseases

  • Chapter
  • First Online:
Cardiology in Family Practice

Part of the book series: Current Clinical Practice ((CCP,volume 1))

  • 1015 Accesses

Abstract

Aortic stenosis (AS) occurs when there is obstruction of blood flow across the aortic valve. AS can result from a congenitally abnormal valve, rheumatic fever, or degenerative/calcific disease. The incidence of the various etiologies differs according to age at presentation. In children, AS generally results from a congenital abnormality. This is either a supravalvular or subvalvular obstruction, or occasionally valvular stenosis, usually in the form of a unicuspid valve in which two of the three commissures are fused, resulting in obstruction and symptoms in infancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844–53.

    PubMed  CAS  Google Scholar 

  2. Fenoglio Jr JJ, McAllister Jr HA, DeCastro CM, Davia JE, Cheitlin MD. Congenital bicuspid aortic valve after age 20. Am J Cardiol. 1977;39:164–9.

    Article  PubMed  Google Scholar 

  3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7.

    Article  PubMed  CAS  Google Scholar 

  4. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–5.

    Article  PubMed  CAS  Google Scholar 

  5. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–4.

    Article  PubMed  CAS  Google Scholar 

  6. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162:2345–7.

    Article  PubMed  Google Scholar 

  7. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146–62.

    Article  PubMed  Google Scholar 

  8. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1–148.

    Article  PubMed  Google Scholar 

  9. Bonow RO, Carabello B, De Leon Jr AC. et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949–84.

    PubMed  CAS  Google Scholar 

  10. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26:1309–13.

    Article  PubMed  Google Scholar 

  11. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291–5.

    Article  PubMed  CAS  Google Scholar 

  12. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723–30.

    Article  PubMed  CAS  Google Scholar 

  13. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–97.

    Article  PubMed  CAS  Google Scholar 

  14. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54.

    Article  PubMed  Google Scholar 

  15. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  PubMed  CAS  Google Scholar 

  16. Khan SS, Gray RJ. Valvular emergencies. Cardiol Clin. 1991;9:689–709.

    PubMed  CAS  Google Scholar 

  17. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol. 1994;24:1046–53.

    Article  PubMed  CAS  Google Scholar 

  18. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689–94.

    Article  PubMed  CAS  Google Scholar 

  19. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of stenotic mitral valve, other cardiac values and central circulatory shunts. Am Heart J. 1951;41:1–29.

    Article  PubMed  CAS  Google Scholar 

  20. Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–84.

    Article  PubMed  CAS  Google Scholar 

  21. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60:299–308.

    Article  PubMed  CAS  Google Scholar 

  22. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:457S–82S.

    Article  PubMed  CAS  Google Scholar 

  23. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up. Circulation. 1982;65:181–7.

    Article  PubMed  CAS  Google Scholar 

  24. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J. 2000;139:596–608.

    Article  PubMed  CAS  Google Scholar 

  25. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–8.

    Article  PubMed  Google Scholar 

  26. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022–8.

    PubMed  CAS  Google Scholar 

  27. Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA, Pless JE. Etiology of pure tricuspid regurgitation based on anular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. J Am Coll Cardiol. 1986;7:1063–74.

    Article  PubMed  CAS  Google Scholar 

  28. Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation – part I. Clin Cardiol. 1995;18:97–102.

    Article  PubMed  CAS  Google Scholar 

  29. Rivera JM, Vandervoort PM, Vazquez de Prada JA, et al. Vazquez de Prada JA, et al. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? Am J Cardiol. 1993;72:1305–9.

    Article  PubMed  CAS  Google Scholar 

  30. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.

    Article  PubMed  Google Scholar 

  31. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79:127–32.

    Article  PubMed  Google Scholar 

  32. Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;24:696–702.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cooper University Hospital, Camden, NJ, USA

    Steven Hollenberg

  2. Robert Wood Johnson Medical School, University of Medicine and Dentistry of Section of Cardiology Cooper University Hospital, Camden, NJ, USA

    Stephen Heitner

Authors
  1. Steven Hollenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Heitner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven Hollenberg .

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hollenberg, S., Heitner, S. (2012). Valvular Diseases. In: Cardiology in Family Practice. Current Clinical Practice, vol 1. Humana Press. https://doi.org/10.1007/978-1-61779-385-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-385-1_6

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-384-4

  • Online ISBN: 978-1-61779-385-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation